Brigit Biofarmaka Teknologi Tbk. vs Tembaga Mulia Semanan Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Tembaga Mulia Semanan Tbk. trades at Rp1,225 (market cap 914.68B, 5.9K 24h volume). The key difference: Tembaga Mulia Semanan Tbk. is far larger — about 5.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (592.2K versus 5.9K). Which is the better fit depends on your goals.
| OBAT | TBMS | |
|---|---|---|
Market Cap | 172.82B | 914.68B |
Volume | 592.2K | 5.9K |
Lot | 5.92K | 59 |
Turnover | 147.05M | 7.26M |
Average Price | 248.31 | 1,231.27 |
Value | 147.05M | 7.26M |
Indicative Equilibrium Price | 254 | — |
Indicative Equilibrium Volume | 10 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT. Tembaga Mulia Semanan Tbk was incorporated based on the Notarial Deed No. 31 dated February 3, 1977 of Kartini Muljadi, S.H., as amended by Notarial Deed No. 48 dated July 6, 1977 of the same notary. The company has started commercial production since Dec 1979. And started production/assembly of electronics wire/cable in 1993. Drawn wire in 1995 and assembly of optical fibre cable in 1998, tinned copper in 1998.
Read more on TBMS →